SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?


To: James Strauss who wrote (16268)7/13/1999 8:30:00 PM
From: Sergio H  Respond to of 29382
 
IFLO

Jim, I saw the raise in the earnings estimate. Do you know what the price target is? Wedbush set a 12 month price target in April of 4.25 raising it up from 3.

IFLO looks good Jim. There is a strong market for their products, specifically fits in with getting people out of the hospital as quickly as possible. According to S & P research, "alternate site revenues for infusion devices is one of the fastest growing segments in the U.S. health care market, with revenues rising in excess of 20% annually."

I've asked Cary as well as Sergio II to look IFLO over.

Sergio



To: James Strauss who wrote (16268)7/13/1999 9:08:00 PM
From: Sergio H  Read Replies (2) | Respond to of 29382
 
IFLO

Jim, I found the information that I was looking for. You posted a link to the Wedbush report earlier. For anyone interested:

einvestmentbank.com

techstocks.com